| __timestamp | Summit Therapeutics Inc. | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 15635076 | 47795223 |
| Thursday, January 1, 2015 | 23943601 | 50426000 |
| Friday, January 1, 2016 | 23689111 | 70853000 |
| Sunday, January 1, 2017 | 41006114 | 78168000 |
| Monday, January 1, 2018 | 51379106 | 123757000 |
| Tuesday, January 1, 2019 | 32705593 | 140963000 |
| Wednesday, January 1, 2020 | 53274000 | 131773000 |
| Friday, January 1, 2021 | 85352000 | 210328000 |
| Saturday, January 1, 2022 | 51999000 | 235780000 |
| Sunday, January 1, 2023 | 59471000 | 244990000 |
Unlocking the unknown
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Summit Therapeutics Inc. and Travere Therapeutics, Inc. have demonstrated contrasting strategies in their R&D investments.
Summit Therapeutics Inc. has shown a steady increase in R&D expenses, peaking in 2021 with a 445% increase from 2014. This reflects their aggressive pursuit of new therapies. Meanwhile, Travere Therapeutics, Inc. has consistently outspent Summit, with their R&D expenses growing by 413% over the same period, reaching a high in 2023.
These trends highlight the dynamic nature of the biotech industry, where strategic R&D investments can lead to groundbreaking treatments and significant market advantages. As these companies continue to innovate, their R&D spending will remain a key metric to watch.
Comparing Innovation Spending: Pfizer Inc. and Summit Therapeutics Inc.
Research and Development: Comparing Key Metrics for Biogen Inc. and Summit Therapeutics Inc.
Research and Development: Comparing Key Metrics for United Therapeutics Corporation and Summit Therapeutics Inc.
Research and Development Investment: Summit Therapeutics Inc. vs Geron Corporation
Summit Therapeutics Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Summit Therapeutics Inc. and Viridian Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Xenon Pharmaceuticals Inc. vs Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Travere Therapeutics, Inc. and Viridian Therapeutics, Inc.
R&D Insights: How Travere Therapeutics, Inc. and MiMedx Group, Inc. Allocate Funds